Big Pharma II: More mixed earnings on the horizon - MarketWatch
January 25, 2007| Big Pharma II: More mixed earnings on the horizon MarketWatch - Also of interest will be sales of the company's top-selling drugs Remicade, a treatment for rheumatoid arthritis, and the allergy medication Nasonex. ... |
Bristol-Myers posts loss on litigation reserves - MarketWatch
January 25, 2007| Bristol-Myers posts loss on litigation reserves MarketWatch - "The bad news was that Sprycel (leukemia) and Orencia (rheumatoid arthritis) missed our estimates," wrote Merrill Lynch analyst David Risinger, in his note. ... |
Managing arthritis - Vancouver North Shore Outlook
January 25, 2007| Managing arthritis Vancouver North Shore Outlook, Canada - She has had rheumatoid arthritis for more than 30 years. She says it can be easy to justify not leaving the house by saying you can’t, you’re sick. ... |
Low-dose steroids reduce joint damage from rheumatoid arthritis - innovations report
January 25, 2007| Low-dose steroids reduce joint damage from rheumatoid arthritis innovations report, Germany - This medication is often prescribed in the first few months after diagnosis to relieve the discomfort of RA until slower-acting drugs begin protecting the ... |
The Pittsburgh Life Sciences Greenhouse Announces Launch of ... - PR Newswire (press release)
January 25, 2007| The Pittsburgh Life Sciences Greenhouse Announces Launch of ... PR Newswire (press release), NY - The need for a more precise and consistent way to diagnose and plan treatment for inflammation caused by rheumatoid arthritis provided the springboard for ... |